BioCryst Pharmaceuticals
BCRX
#5122
Rank
NZ$2.70 B
Marketcap
NZ$10.93
Share price
-1.35%
Change (1 day)
-22.97%
Change (1 year)

Market capitalization of BioCryst Pharmaceuticals (BCRX)

Market cap: NZ$2.70 Billion

As of February 2026 BioCryst Pharmaceuticals has a market cap of NZ$2.70 Billion. This makes BioCryst Pharmaceuticals the world's 5122th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioCryst Pharmaceuticals from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.70 B-2.39%
2025NZ$2.77 B-1.95%
2024NZ$2.83 B45.97%
2023NZ$1.93 B-42.45%
2022NZ$3.37 B-7.61%
2021NZ$3.64 B100.13%
2020NZ$1.82 B130.97%
2019NZ$0.78 B-40.39%
2018NZ$1.32 B94.64%
2017NZ$0.68 B0.93%
2016NZ$0.67 B-39.06%
2015NZ$1.10 B-0.95%
2014NZ$1.11 B104.34%
2013NZ$0.54 B522.1%
2012NZ$87.84 M-38.61%
2011NZ$0.14 B-52.51%
2010NZ$0.30 B-22.85%
2009NZ$0.39 B332.37%
2008NZ$90.31 M-70.52%
2007NZ$0.30 B-36.18%
2006NZ$0.47 B-32.03%
2005NZ$0.70 B300.63%
2004NZ$0.17 B-6.41%
2003NZ$0.18 B481.44%
2002NZ$32.38 M-80.71%
2001NZ$0.16 B-35.96%
2000NZ$0.26 B-73.1%
1999NZ$0.97 B390.43%
1998NZ$0.19 B19.21%
1997NZ$0.16 B-47.5%
1996NZ$0.31 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of BioCryst Pharmaceuticals was reported to be:

NZ$2.30 Billion
by Nasdaq info icon info icon
NZ$2.70 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$292.45 B 10,691.79%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$173.15 B 6,289.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
NZ$3.53 B 30.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$13.96 B 415.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
NZ$2.38 B-11.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$2.71 B 0.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$34.55 M-98.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$80.97 M-97.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.00 B-62.93%๐Ÿ‡บ๐Ÿ‡ธ USA